Use of alfacalcidol in osteoporotic patients with low muscle mass might increase muscle mass: An investigation using a patient database

Geriatrics and Gerontology International

Volumn 14, Issue SUPPL.1, 2014, Pages 122-128

  Ito, Sadayuki ^a   Harada, Atsushi ^a   Kasai, Takehiro ^a   Sakai, Yoshihito ^a   Takemura, Marie ^a   Matsui, Yasumoto ^a   Hida, Tetsuro ^b   Ishiguro, Naoki ^b  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Aging; Alfacalcidol; Muscle strength; Osteoporosis; Sarcopenia

Indexed keywords

ALFACALCIDOL;

AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MUSCLE MASS; OSTEOPOROSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKELETAL MUSCLE; TREATMENT OUTCOME;

AGING; ALFACALCIDOL; MUSCLE STRENGTH; OSTEOPOROSIS; SARCOPENIA;

ABSORPTIOMETRY, PHOTON; AGED; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYCHOLECALCIFEROLS; MALE; MUSCLE, SKELETAL; OSTEOPOROSIS; RETROSPECTIVE STUDIES; SARCOPENIA;

EID: 84892884979     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/ggi.12222     Document Type: Article

References (30)

1. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr 1997; 127: 990S-991S.
2. Batista FS, Gomes GA, Neri AL etal. Relationship between lower-limb muscle strength and frailty among elderly people. Sao Paulo Med J 2012; 130: 102-108.
3. Abate M, Di Iorio A, Di Renzo D, Paganelli R, Saggini R, Abate G. Frailty in the elderly: the physical dimension. Eura Medicophys 2007; 43: 407-415.
4. Hida T, Ishiguro N, Shimokata H etal. High prevalence of sarcopenia and reduced leg muscle mass in Japanese patients immediately after a hip fracture. Geriatr Gerontol Int 2013; 13: 413-420.
5. Go SW, Cha YH, Lee JA, Park HS. Association between sarcopenia, bone density, and health-related quality of life in Korean men. Korean J Fam Med 2013; 34: 281-288.
6. Evans WJ. Protein nutrition, exercise and aging. J Am Coll Nutr 2004; 23: 601S-609S.
7. Kamel HK, Maas D, Duthie EH Jr. Role of hormones in the pathogenesis and management of sarcopenia. Drugs Aging 2002; 19: 865-877.
8. Pereira LS, Narciso FM, Oliveira DM, Coelho FM, Souza Dda G, Dias RC. Correlation between manual muscle strength and interleukin-6 (IL-6) plasma levels in elderly community-dwelling women. Arch Gerontol Geriatr 2009; 48: 313-316.
9. Roubenoff R. Catabolism of aging: is it an inflammatory process? Curr Opin Clin Nutr Metab Care 2003; 6: 295-299.
10. Christakos S, Hewison M, Gardner DG etal. Vitamin D: beyond bone. Ann N Y Acad Sci 2013; 1287: 45-58.
11. Bischoff HA, Borchers M, Gudat F etal. In situ detection of 1, 25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem J 2001; 33: 19-24.
12. Gillespie LD, Robertson MC, Gillespie WJ etal. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 2009; (15)CD007146. doi: 10.1002/14651858.CD007146.pub2
13. Baumgartner RN, Koehler KM, Gallagher D etal. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998; 147: 755-763.
14. Sanada K, Miyachi M, Tanimoto M etal. A cross-sectional study of sarcopenia in Japanese men and women: reference values and association with cardiovascular risk factors. Eur J Appl Physiol 2010; 110: 57-65.
15. Kalyani RR, Stein B, Valiyil R, Manno R, Maynard JW, Crews DC. Vitamin D treatment for the prevention of falls in older adults: systematic review and meta-analysis. J Am Geriatr Soc 2010; 58: 1299-1310.
16. Stockton KA, Mengersen K, Paratz JD, Kandiah D, Bennell KL. Effect of vitamin D supplementation on muscle strength: a systematic review and meta-analysis. Osteoporos Int 2011; 22: 859-871.
17. Chen L, Nelson DR, Zhao Y, Cui Z, Johnston JA. Relationship between muscle mass and muscle strength, and the impact of comorbidities: a population-based, cross-sectional study of older adults in the United States. BMC Geriatr 2013; 13: 74.
18. Bischoff HA, Dawson B, Staehelin HB etal. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 2009; 339: b3692.
19. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 2005; 29 (1): 21-30.
20. Moreland JD, Richardson JA, Goldsmith CH, Clase CM. Muscle weakness and falls in older adults: a systematic review and meta-analysis. J Am Geriatr Soc 2004; 52: 1121-1129.
21. Endo I, Inoue D, Mitsui T etal. Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 2003; 144: 5138-5144.
22. Bischoff-Ferrari HA, Borchers M, Gudat F, Dürmüller U, Stähelin HB, Dick W. Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res 2004; 19: 265-269.
23. Scharla SH, Schacht E, Lempert UG. Alfacalcidol versus plain vitamin D in inflammation induced bone loss. J Rheumatol Suppl 2005; 76: 26-32.
24. Schacht E, Richy F, Reginster JY. The therapeutic effects of alfacalcidol on bone strength, muscle metabolism and prevention of falls and fractures. J Musculoskelet Neuronal Interact 2005; 5: 273-284.
25. Visser M, Pahor M, Taaffe DR etal. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci 2002; 57: 326-332.
26. Pahor M, Kritchevsky S. Research hypotheses on muscle wasting, aging, loss of function and disability. J Nutr Health Aging 1998; 2: 97-100.
27. Zhang Y, Leung DY, Richers BN etal. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol 2012; 188: 2127-2135.
28. Visser M, Deeg DJ, Lips P, Longitudinal Aging Study Amsterdam. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 2003; 88: 5766-5772.
29. Verdijk LB, Koopman R, Schaart G, Meijer K, Savelberg HH, van Loon LJ. Satellite cell content is specifically reduced in type II skeletal muscle fibers in the elderly. Am J Physiol Endocrinol Metab 2007; 292: E151-E157.
30. Sato Y, Iwamoto J, Kanoko T, Satoh K. Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial. Cerebrovasc Dis 2005; 20: 187-192.